Background: Studies have often stated that individual-level determinants are important drivers for the adoption of medical devices. Empirical evidence supporting this claim is, however, scarce. At the individual level, physicians' adoption motivation was often considered important in the context of adoption decisions, but a clear notion of its dimensions and corresponding measurement scales is not available. Objectives: To develop and subsequently validate a scale to measure the motivation to adopt medical devices of hospital-based physicians. Methods: The development and validation of the physician-motivation-adoption (PMA) scale were based on a literature search, internal expert meetings, a pilot study with physicians, and a three-stage online survey. The data collected in the online survey were analyzed using exploratory factor analysis (EFA), and the PMA scale was revised according to the results. Confirmatory factor analysis (CFA) was conducted to test the results from the EFA in the third stage. Reliability and validity tests and subgroup analyses were also conducted. Results: Overall, 457 questionnaires were completed by medical personnel of the National Health Service England. The EFA favored a six-factor solution to appropriately describe physicians' motivation. The CFA confirmed the results from the EFA. Our tests indicated good reliability and validity of the PMA scale. Conclusions: This is the first reliable and valid scale to measure physicians' adoption motivation. Future adoption studies assessing the individual level should include the PMA scale to obtain more information about the role of physicians' motivation in the broader adoption context.
Introduction
Decisions regarding whether to adopt a certain technology are among the most important medical and administrative decisions made in health care systems in general and in hospitals in particular [1] The process of adoption is, however, complex and influenced by many interacting factors [2, 3] . Factors that the literature has identified as being relevant to the adoption process have been categorized into four levels: the environmental, the organizational, the individual, and the innovation level. Thus far, research has predominantly focused on the organizational level [4] . The individual level has received less attention even though adoption decisions in hospitals are made by (groups of) individuals and underlie subjective influences [5, 6] . Especially physicians largely impact the adoption of innovations in hospitals because they serve as initiators, supporters, and decision makers [1, [5] [6] [7] . Physicians' motivation has often been cited as crucial to adoption although empirical evidence supporting this assumption is rather scarce [2, 8, 9] . This notion is even more important considering that adoption decisions are also made in the absence of medical evidence for a medical technology [10] . In general, the motivation to adopt innovations-also described as innovativeness-is a multidimensional construct, and the sources of this motivation are manifold [11] [12] [13] . Defining the motivation construct entails complexity, which likely explains the lack of consistent and standard measurement methods [9] . A reliable and valid measurement scale is an option to systematically incorporate motivation into future adoption research [12] . To increase the applicability of a scale, one should ensure that it can be used across different medical technologies and specialties. Nevertheless, the attributes of medical technologies differ, which is also reflected in adoption decisions. For example, medical devices feature functional aspects (i.e., size, form, usability, and learning efforts) that are relevant to the physician and that do not exist in or are not equally important for other health technologies such as pharmaceuticals. Normally, if such differences are not considered, the validity of a single scale decreases.
Therefore, the objective of this study was to develop and validate a scale to measure physicians' individual motivation to adopt medical devices excluding other medical technologies and components influencing adoption decisions that are not located on an individual level (e.g., objective medical evidence or financial criteria). The goal was to develop a scale that is applicable across medical devices and specialties. The scale was developed to target hospital-based physicians. The data used to develop and validate the scale were obtained from the literature, face-to-face and telephone interviews conducted with physicians in a pilot study, and a subsequent online survey of physicians used by the National Health Service (NHS) England. The data were analyzed using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA).
Theoretical Background
To our knowledge, there are no theories or conceptual frameworks that were specifically designed to explain the influence of physicians' motivation on technology adoption in a health care context. Nevertheless, related theories exist that try to explain how technological or behavioral adoption occurs on an individual level, such as the innovation diffusion theory [14] , the technology acceptance model (TAM) [15] [16] [17] , the theory of reasoned action (TRA) [18] , or the theory of planned behavior (TPB) [19] . Although these theories do not focus on individual motivation per se, they include elements such as social influence, subjective norms, or perceived usefulness that are related to the motivation concept. The relevance of social and functional aspects for adoption decisions is also acknowledged in the consumer innovativeness and motivation literature [11, 12, [20] [21] [22] . In addition, authors of the innovativeness literature identify cognitive and hedonic aspects as being important drivers of one's motivation to adopt [11, 21] .
The behavioral adoption theories and the innovativeness and motivation literature have common ground and offer general elements that can serve as a theoretical starting point to study physicians' motivation to adopt medical technologies. Nevertheless, a useful scale has to operationalize these general elements with respect to the specific characteristics of physicians' adoption situations in health care. In health care, physicians are concerned with decisions to adopt technologies that are used for the treatment of patients. This is a major difference compared with adoption decisions in a consumer context in which the adopted technologies are used for oneself. Therefore, it is necessary to incorporate an additional component capturing physicians' motivation to improve patients' benefit by adopting medical technologies [23] . Similar attempts have been made in studies that have tried to operationalize TAM, TRA, or TPB in a health care context but they have suffered from a lack of standardization [24, 25] . Furthermore, these studies have subsumed patient benefit under perceived usefulness (i.e., in the form of increased quality of care or efficiency) and have not perceived the need to implement a separate dimension [24] . For our scale we have built on the adoption and innovativeness literature and thus have incorporated social, functional, hedonic, and cognitive elements as well as physicians' orientation toward patients.
Methods

Initial Item Collection
Because no specific scale assessing the adoption of medical devices is currently available, we used the validated, multidimensional innovativeness scale developed by Vandecasteele and Geuens as the starting point of our item collection [11, 12] . This scale, which was developed to analyze the consumer-product relationship, includes rather general dimensions that we assumed are also relevant in health care settings. The scale describes the concept of innovativeness through four dimensions, that is, functional, hedonic, social, and cognitive, that are based on goals and values underlying human actions [26, 27] . In addition to extracting items from this scale, we searched the adoption and innovativeness literature for related concepts [21, 22, 24, 25, 28, 29] and generated new items when appropriate. The items identified in our initial collection were further discussed and refined in meetings held with five health economists. The refinement consisted of adding and excluding items, changing item wording, and structuring the item selection. After the refinement process, our scale comprised six dimensions (i.e., Functional, Conformity, Power, Hedonic, Patient Benefit, and Cognitive) including 34 items.
Pilot Study
To increase the validity of the initial item selection, we conducted a pilot study comprising face-to-face and telephone interviews with 19 physicians with different medical specialties. During the in-depth interviews, the comprehensibility, relevance, completeness, wording, and order of the selected items were evaluated. All physicians confirmed the comprehensibility, relevance, and completeness of the proposed dimensions. The wording and order of the items were, however, revised on the basis of physicians' feedback, and some items were deleted or consolidated so that the initial scale distributed online comprised 28 items (see Appendix A in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.2016.12.002).
Data Collection
Data collection was carried out using an online survey that was administered via EFS survey software (QuestBack, Oslo, Norway). The objective was to develop a scale that can be used in a medical context and is flexible enough to be completed by physicians with different specialties who had been involved in decisions to adopt medical devices.
Invitation letters were sent via email to physicians listed in the Named Clinician Report (as of June 2011) of the NHS Digital, which is an executive nondepartmental public body of the Department of Health. The Department of Health is responsible for England. Email addresses were constructed on the basis of names and health care provider information obtained from the report. The physicians were contacted in three consecutive stages, and the observations collected in each stage were analyzed using EFA. After each stage, we revised the scale according to the results. In stage 1, all physicians were invited to participate in the survey. In stage 2, reminders were sent to the physicians. Finally, in stage 3, all physicians, including those who had already responded to the survey, were again asked to participate in the final version of the survey. Overall, the data collection phase ran from August 12, 2015, to September 21, 2015.
Measurement
Invited physicians were asked to think of real adoption decisions that they had been involved in. This method ensured that the collected data were based on different kinds of medical devices and reflected realistic situations. All items of the six postulated motivation dimensions were measured on a five-point Likert scale. Respondents reported their agreement with the item statements using the following response options: strongly disagree, disagree, neutral, agree, and strongly agree. In addition, we measured the relative importance of the dimensions by asking the participants to allocate 100 points in total to the six dimensions.
Filter questions were included at the beginning of the survey to determine whether physicians had been actively involved in
decisions to adopt medical devices. Respondents who were not involved in such decisions were excluded. We also asked the physicians to provide an estimate of how strong their influence on the adoption decision is. The corresponding item ranged from 1 (no influence on the adoption decision) to 6 (very strong influence on the adoption decision). Additional questions about respondent and hospital characteristics (e.g., position in hospital hierarchy, medical specialty, and hospital size) were included at the end of the survey.
Data Preparation and Analysis
Before we conducted the EFA, we tested sampling adequacy using the Kaiser-Meyer-Olkin (KMO) criterion [30, 31] . KMO values range between 0 and 1, and values above 0.9 are considered as marvelous [32] . For the EFA, we chose to perform principal axis factoring because our aim was to check whether the shared variance of our items can be explained by unobservable constructs (i.e., latent hypothetical constructs or factors) rather than to simply reduce the number of items on the basis of complete variance [33] [34] [35] . Although an EFA is not an exact method of testing theoretical hypotheses, it allows us to draw conclusions about the construct validity of self-report scales [31, 36] . The number of factors extracted was based on our preceding theoretical considerations, the KMO criterion (all eigenvalues 41), a corresponding scree plot, and parallel analysis [34, 35] . As recommended in the literature, promax (oblique) rotation was applied to the principal axis factoring results to achieve better interpretability of the results [34, 37, 38] . Promax rotation allows factors to be correlated, an assumption that cannot be overlooked [35, 39] . To test the scale's internal consistency reliability, we calculated Cronbach alpha [40] . Although items that load onto a specific factor should show high intercorrelations, that is, high internal consistency, items across different factors should exhibit low correlations [41, 42] . We applied the described methods to the data collected in each stage of our survey. After each stage, we deleted or reworded items with factor loadings lower than 0.32 or which loaded onto two or more factors [43] .
A CFA was conducted on the results from the final EFA to test the postulated relationships between latent constructs and items [44] . It was conducted using data from stage 3 of our collection phase. The model was estimated using maximum likelihood. The chi-square value, the root mean square error of approximation (RMSEA), the standardized root mean square residual (SRMR), the Tucker-Lewis index (TLI), and the comparative fit index (CFI) were used to evaluate model fit [44, 45] . We calculated several different goodness-of-fit indices because there is substantial discussion about the reliability of the indices and their threshold values to evaluate model fit [39, 43, 44] .
A good model fit is achieved if the null hypothesis of a likelihood ratio test on the basis of the chi-squared distribution is rejected [39] . RMSEA values lower than 0.05 indicate good model fit, values from 0.05 to 0.08 acceptable fit, and values from 0.08 to 0.1 marginal fit [39] . SRMR values lower than 0.1 point to an acceptable model fit [43] . The CFI and TLI values should be larger than 0.95 [46] . Furthermore, we assessed the reliability of our scale by calculating composite reliability scores [47, 48] and its validity by analyzing convergent and discriminant validity on the basis of a comparison of the average variance extracted (AVE) and the squared correlation values [41, 49] . Covergent validity is evident if the amount of variance explained by the latent construct is greater than the variance based on measurement error, that is, if the AVE value is higher than 0.5 [49] . Discriminant validity is evident if the AVE values are higher than the squared correlation values [49] . Together, convergent and discriminant validity are strong indicators of construct validity [41, 50] . Content validity was addressed through the pilot study [41] . All data analyses were conducted using STATA 13 SE (StataCorp LP, College Station, TX).
Results
Descriptive Results
In total, we were able to identify the email addresses of 13,596 individuals listed in the Named Clinician Report; nevertheless, approximately one-third of the email addresses were obsolete at the time we distributed the questionnaire. A total of 230 questionnaires were completed in the first stage (completed after 14 days; see results of the first EFA in Appendix A in Supplemental Materials), 99 in the second stage (completed after 19 days; see results of the second EFA in Appendix B in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.2016.12.002), and 128 in the final stage (completed after another 14 days), resulting in a total of 457 questionnaires received. After excluding physicians who had not been involved in the adoption of medical devices or who did not have influence on the adoption decision, 365 completed questionnaires remained. For the three stages of our analysis, the item used to measure respondents' influence on the adoption decision had a mean value of 4.91 Ϯ 0.80, 4.73 Ϯ 0.89, and 4.98 Ϯ 0.82, respectively. This result is equivalent to a strong influence. In the third stage, the sample almost exclusively consisted of physicians who were older (i.e., 46-55 years or 56-65 years) and male (see Table 1 ). All the following results presented refer to the final stage of the survey because it included the revised and final version of the physician-motivationadoption scale (PMA scale). Results for stages 1 and 2 are presented in Appendices A and B, respectively, in Supplemental Materials.
Exploratory and Confirmatory Factor Analyses
The KMO value was 0.76, which is referred to as "middling" (values higher than 0.7 are deemed to be acceptable) [32, 41] . In addition, none of the single items had a value lower than 0.5.
We extracted six factors on the basis of the KMO criterion (all eigenvalues 41), the scree plot (bend between the sixth and seventh factors), and the parallel analysis (see Fig. 1 ) [34, 38, 39] . The total variance explained by the six factors was 94.39%. After promax rotation, the structure of the factor loadings was confirmed, and no substantial cross-loadings were found (see Table 2 ).
CFA confirmed the postulated relationships between items and latent constructs. All standardized factor loadings were higher than 0.4 and significant (P o 0.01). CFA results and goodness-of-fit indicators are presented in Table 3 . The chisquared statistic was 507.27 and the null hypothesis of the corresponding likelihood ratio test was not rejected. The RMSEA value for our model was 0.08, indicating at least marginal fit. The SRMR value for our model was 0.09, indicating an acceptable model fit. The CFI and TLI values were 0.87 and 0.86, respectively, indicating suboptimal model fit.
Reliability and Validity Tests and Subgroup Analysis
The values for Cronbach alpha ranged from 0.74 to 0.94. This suggests that the factors have good internal consistency reliability (see Table 2 ) [41, 51] . Composite reliability values derived from the CFA results ranged from 0.75 to 0.94, indicating good composite reliability [52] .
Furthermore, different aspects of validity, including discriminant, convergent, and content validity, were evaluated. AVE and squared correlation values of the latent constructs are presented in Table 4 . The AVE values of all the factors were higher than
their squared correlation values, and therefore we can assume discriminant validity. In addition, all AVE values except the AVE value for the Patient Benefit factor were higher than 0.5, which indicates convergent validity of the remaining factors. The physicians who participated in the pilot study confirmed the relevance of the suggested items and factors; that is, they provided evidence for content validity [36] .
Subgroup analyses using EFA were conducted for three subgroups on the basis of the data from the final validation round. Respondents who indicated that they provided their answers on the basis of implantable devices (43 observations) and diagnostic devices (59 observations) formed the first subgroup and second subgroup, respectively. In addition, a third subgroup analysis was specifically carried out on observations from physicians (6 of the 102 observations in stage 3 were derived from other medical personnel).
Again, all subgroup analyses resulted in six-factor solutions, and the loading patterns were nearly identical to the base case. As the number of observations decreased, cross-loadings could be observed for three items in the first subgroup analysis (i.e., implantable devices). No cross-loadings were found in the second and third subgroup analyses, confirming the structure of the PMA scale. For all subgroup analyses, the internal consistency reliability, as measured by Cronbach alpha, was satisfactory to excellent. (All these results are available from the authors on request.)
The PMA Scale and Factor Weightings
We termed the six resulting factors "Functional," "Conformity," "Power," "Hedonic," "Patient Benefit," and "Cognitive." Considering the relative importance of the factors, the Patient Benefit factor had the highest ranking, with 51.09 Ϯ 22.89 percentage points, whereas the "Power" factor had the lowest ranking, with 2.96 Ϯ 4.09 percentage points (see Table 2 ). The final 27-item PMA scale is presented in Table 5 . NHS, National Health Service. * n refers to the number of completed questionnaires after excluding physicians who had not adopted medical devices and physicians who had no influence on adoption decisions.
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Discussion
The EFA and the CFA revealed that physicians' motivation to adopt medical devices can be measured using the PMA scale, which consists of six distinct dimensions. These dimensions are theoretically meaningful, and we interpret them as follows.
The first dimension, which we termed Functional, is similar to the "functional" dimension of the scale developed by Vandecasteele and Geuens [11] and to the constructs "perceived usefulness" and "perceived ease of use" of the TAM [15] [16] [17] . It captures the increase in utility or functionality related to the adoption of a medical device. Hence, the underlying motivation for adopting medical devices is to gain a functional or technical advantage.
The second dimension, which we termed Patient Benefit, describes physicians' superordinate motivation to improve patients' well-being. This dimension should not be confused with actual medical evidence. It was designed to capture physicians' individual perceptions of any beneficial medical aspects of a medical device. These perceptions do not have to be in line with actual medical evidence in the sense of randomized controlled trial data. Instead, medical evidence needs to be considered in addition to the dimensions of the PMA scale when studying adoption decisions. To avoid physicians' trivial confirmation of the importance of the Patient Benefit dimension, the corresponding items imply a trade-off between the benefits and the drawbacks of adoption. This was done to measure how much value physicians assign to the perceived patient benefit of a certain medical device. For instance, if a physician is strongly convinced of the beneficial aspects of a medical device, this physician would probably try to foster the adoption of that device even in the context of potential adoption hurdles (e.g., learning efforts and interference with routine processes). Our findings indicate that physicians consider the Patient Benefit dimension to be highly important in the adoption context (see factor weightings). In line with this result, Teplensky et al. [23] considered patient orientation as physicians' predominant motivation for adoption.
The third dimension, Power, includes motives such as superiority, self-determination, and recognition. These motives describe physicians' desire to improve their own situation and gain personal advantages [11, 27] . The basic notion is that the adoption of a medical device can lead to a more successful career. A related concept is evident in the "social" dimension of the scale developed by Vandecasteele and Geuens [11] .
The fourth dimension, Conformity, describes the desire to conform to peers and colleagues. It is assumed that adoption behavior reflects physicians' desire to align with the norm or to meet expectations [16, 27] . In this case, the adoption of a medical device could be used to close the gap with peers who have or have not made an adoption decision. A similar concept can be found in the TAM [16] .
The fifth dimension, Hedonic, describes a personal desire to obtain the latest products and is related to positive feelings of enjoyment and satisfaction triggered by the adoption of a medical device. A similar concept in the field of consumer research can be found in the scale developed by Vandecasteele and Geuens [11] .
The sixth dimension, Cognitive, captures physicians' desire for cognitive stimulation and to expand their own cognitive limits. It is assumed that medical devices can be adopted to 
satisfy a desire for cognitive stimulation. This dimension is also similar to the "cognitive" dimension of the scale developed by Vandecasteele and Geuens [11, 26] . Although a rather small number of observations were available for each round of validation, the overall characteristics of the sample were favorable. In particular, our sample consisted of responses from actual decision makers who indicated that they had a strong influence on adoption decisions. Moreover, all responding physicians were consultants and predominantly worked in large hospitals with more than 500 beds. Accordingly, our results are based on a sample Note. AVE estimates are displayed in boldface on the diagonal; squared correlation values are presented below the diagonal. AVE, average variance extracted; CFA, confirmatory factor analysis.
from the desired target population, that is, physicians involved in the adoption of medical devices. Regarding the PMA scale, the EFA revealed a uniform structure of factor loadings without cross-loadings, allowing a clear interpretation of the latent constructs. The CFA confirmed the structure of the PMA scale. Model fit was acceptable regarding RMSEA and SRMR, but suboptimal regarding chi-squared, CFI, and TLI. It is known that model fit assessment is difficult given the small sample size [46] , and thus we believe that further goodness-of-fit assessments with larger sample size will be necessary in future studies. Reliability based on composite reliability was again favorable, with values exceeding 0.7. Convergent and discriminant validity were also confirmed except convergent validity for the Patient Benefit dimension. The AVE value for the Patient Benefit dimension was lower than 0.5, which means that the average amount of variance of the items explained by the Patient Benefit dimension was less than 50%. It was, however, higher than the squared correlation value, indicating that the items measure a distinct dimension. It is possible that further item deletion will solve this problem (and increase model fit); nevertheless, we think that this should be done using new data with more observations.
Limitations
This study is subject to limitations. The sample size used was rather small. This is especially true for the samples collected in stages 2 and 3. Although a general rule for a minimum sample size has yet not been defined [31] , authors recommend a sample size of at least 100 observations or recommend a certain number of items to number of participants ratio [38, 39, 53] . We believe that the moderate model fit based on CFA was influenced by the small sample size in stage 3 and we advise authors to run a CFA and test the model's goodness of fit before using the PMA scale. With new data it should also be possible to test whether deleting items increases model fit and convergent validity of the Patient Benefit dimension.
A social desirability bias may have influenced the Power and Patient Benefit dimensions. From a social or moral perspective, it is generally not perceived desirable for a physician to admit that personal gain was the motivation for adoption (e.g., for career reasons). Therefore, we expected a tendency toward lower values of agreement for the power dimension. The bias concerning the Patient Benefit dimension should be in the opposite direction because helping patients is viewed as a physician's primary goal. Because decisions to adopt a device are made by physicians who act as representatives for the actual consumer (i.e., the patients), physicians' personal goals are expected to play a lesser role in adoption decisions than would the goals of the affected individuals. We assumed that the single items within the dimensions are equally affected by the biases. Therefore, the validity of the scale should not have been affected because the structure of the items, rather than the raw values, is important.
It is possible that our study was prone to self-selection bias. Physicians with a distinct willingness to help patients might also be more likely to participate in a survey study. Therefore, physicians with a different attitude might have been underrepresented in our study. Although this is a rather general limitation that applies to various types of survey research, we recommend that researchers interpret the values of the items conservatively with the understanding that the true values might be higher (e.g., Power) or lower (e.g., Patient Benefit). Nevertheless, again, the validity of the PMA scale should not have been affected by self-selection bias.
Our study was validated using questionnaires completed by physicians employed by the NHS England. Researchers should be aware that our results might differ from those based on data collected in another population of physicians. For example, the typical career paths of physicians in other countries could vary, potentially affecting the mean value of the Power dimension. Furthermore, different health care systems could alter the decision autonomy of physicians. Nevertheless, we are convinced that heterogeneity does not impact the structure of our scale because it does not impact the loading patterns of items or the existence of motivation dimensions. Instead, heterogeneity is more likely to influence the relative importance of the items and dimensions and the relative impact of physicians' motivation to adopt on adoption decisions. Therefore, we advise researchers to conduct a CFA before administering the PMA scale in other populations of physicians [54] .
Recommendations for the Application of the PMA Scale
The PMA scale was designed to capture physicians' individual motivation to adopt medical devices. This implies that the PMA scale alone is not sufficient to comprehensively explain adoption PMA, physician-motivation-adoption.
decisions. Other factors such as medical evidence, financial criteria, or manufacturer support are also important components of adoption decisions and need to be considered in addition to the PMA scale. Therefore, it is possible that factors such as medical evidence superimpose other factors such as physicians' motivation regarding their impact on adoption decisions. Nevertheless, to get more insights about these relationships and the relative importance of different factors, further research that includes the PMA scale is needed.
Implications for Future Research
Several aspects of the dimensions of the PMA scale must be discussed in future research. First, it should be further explored whether a high or low agreement with a motivational dimension increases the likelihood of adoption of a medical device. For example, during our pilot study most physicians emphasized that an increase in patients' benefit is their primary motivation for adopting medical devices. The same physicians also stated to be very hesitant to adopt medical devices in general and to strongly rely on medical evidence. These statements do not contradict each other. Instead, this might indicate that physicians who place more weight on patients' benefit when considering the adoption of a medical device might be more risk-averse and might therefore have a lower likelihood of adoption unless strong and unequivocal medical evidence for using the medical device becomes available. Second, future research should explore whether physicians who agree with the Hedonic and Power dimensions tend to be early adopters and whether these physicians have a higher likelihood of adopting medical devices in general. It should also be clarified whether these assumptions hold in general or are specific to certain medical devices.
Third, researchers should also investigate whether physicians' motivation to adopt changes over a device's life cycle. For example, one might assume that hedonic or cognitive motivations are present only in the case of "new" innovations and that these can "wear off" with time.
Finally, research should explore whether physicians' motivation overlaps with other factors that influence the adoption decision (e.g., medical evidence, financial aspects, and manufacturer activities) and how its relative importance can be assessed.
Conclusions
Although physicians' motivation has been widely recognized as an important factor in the adoption of medical devices, it was a challenge to measure the latent construct because validated scales were not available [2] . The PMA scale is a consistent and valid tool for systematically measuring physicians' motivation to adopt different medical devices. It consists of six dimensions, which we interpreted theoretically and termed Functional, Conformity, Power, Hedonic, Patient Benefit, and Cognitive. The implementation of the scale in future research may help to improve our understanding of the role of individual factors in the adoption of medical devices. Moreover, the PMA scale can help to improve our understanding of the role of motivation in group decision making and to expand our knowledge of adoption and subsequent diffusion processes in hospitals.
Taken together, the PMA scale fills an important gap in the literature and can be used to increase the current knowledge of physicians' thought processes and adoption decisions.
